| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 451.69M | 484.18M | 490.18M | 535.32M | 507.41M | 378.60M |
| Gross Profit | 278.65M | 301.99M | 302.15M | 308.12M | 282.11M | 225.94M |
| EBITDA | -25.94M | -18.87M | -20.06M | -46.66M | -58.43M | -18.06M |
| Net Income | -35.28M | -32.88M | -37.01M | -61.52M | -68.30M | -31.39M |
Balance Sheet | ||||||
| Total Assets | 247.98M | 260.63M | 298.59M | 400.42M | 434.06M | 150.86M |
| Cash, Cash Equivalents and Short-Term Investments | 63.43M | 94.02M | 125.50M | 177.91M | 199.40M | 38.28M |
| Total Debt | 82.57M | 85.17M | 87.82M | 133.94M | 138.94M | 115.73M |
| Total Liabilities | 161.51M | 161.11M | 159.21M | 229.88M | 217.00M | 309.83M |
| Stockholders Equity | 86.47M | 99.53M | 139.38M | 170.54M | 217.06M | -158.97M |
Cash Flow | ||||||
| Free Cash Flow | -40.02M | -13.24M | -2.77M | -16.63M | -193.51M | -24.44M |
| Operating Cash Flow | -35.16M | -7.08M | 6.06M | 4.69M | -172.34M | -19.62M |
| Investing Cash Flow | -4.87M | -6.16M | -8.83M | -21.14M | -21.17M | -4.83M |
| Financing Cash Flow | -16.15M | -19.87M | -49.62M | -2.10M | 355.46M | 54.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $41.93B | 9.83 | 13.68% | 3.37% | 16.54% | -3.61% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | $5.50B | 38.48 | ― | ― | 1.98% | -20.98% | |
54 Neutral | $13.48B | 66.05 | 59.58% | ― | 9.80% | -46.84% | |
51 Neutral | $248.94M | -1.19 | -67.22% | ― | -8.07% | -2206.16% | |
51 Neutral | $818.42M | -267.59 | -0.19% | ― | -3.85% | 97.87% | |
48 Neutral | $104.11M | -3.01 | -33.59% | ― | -7.61% | -18.41% |
On December 15, 2025, BARK, Inc. announced that the New York Stock Exchange will commence proceedings to delist and has immediately suspended trading in the company’s publicly listed warrants, which had an $11.50 exercise price and traded under the symbol BARK-WS, citing abnormally low selling prices under NYSE rules; BARK will not appeal the decision, though trading in its common stock will continue on the NYSE under the BARK ticker, subject to ongoing compliance with listing standards, limiting the impact primarily to warrant holders rather than equity shareholders. The company also disclosed that its 2025 Annual Meeting of Stockholders is expected to be held on March 25, 2026, and because the date falls more than 30 days after the prior year’s meeting, it has set December 29, 2025, as the deadline for shareholders to submit proposals, director nominations, and universal proxy nominations in accordance with SEC regulations, Delaware law, and its bylaws for potential inclusion in the proxy materials.